204 related articles for article (PubMed ID: 22889821)
1. Abdominal obesity and cardiovascular disease: is inflammation the missing link?
Després JP
Can J Cardiol; 2012; 28(6):642-52. PubMed ID: 22889821
[TBL] [Abstract][Full Text] [Related]
2. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
3. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
4. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.
Makkonen J; Westerbacka J; Kolak M; Sutinen J; Cornér A; Hamsten A; Fisher RM; Yki-Järvinen H
Int J Obes (Lond); 2007 Oct; 31(10):1617-25. PubMed ID: 17452990
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
7. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
[TBL] [Abstract][Full Text] [Related]
8. Is visceral obesity the cause of the metabolic syndrome?
Després JP
Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
[TBL] [Abstract][Full Text] [Related]
9. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
[TBL] [Abstract][Full Text] [Related]
10. PASSCLAIM--body weight regulation, insulin sensitivity and diabetes risk.
Riccardi G; Aggett P; Brighenti F; Delzenne N; Frayn K; Nieuwenhuizen A; Pannemans D; Theis S; Tuijtelaars S; Vessby B
Eur J Nutr; 2004 Jun; 43 Suppl 2():II7-II46. PubMed ID: 15221353
[TBL] [Abstract][Full Text] [Related]
11. Resistance training, visceral obesity and inflammatory response: a review of the evidence.
Strasser B; Arvandi M; Siebert U
Obes Rev; 2012 Jul; 13(7):578-91. PubMed ID: 22385646
[TBL] [Abstract][Full Text] [Related]
12. Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients.
Zeyda M; Huber J; Prager G; Stulnig TM
Obesity (Silver Spring); 2011 Apr; 19(4):743-8. PubMed ID: 20508627
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat as a determinant of fibrinolysis and hemostasis.
Mertens I; Van Gaal LF
Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
[TBL] [Abstract][Full Text] [Related]
14. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
15. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone and the metabolic syndrome.
Johannsson G; Bengtsson BA
J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
[TBL] [Abstract][Full Text] [Related]
17. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P
Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190
[TBL] [Abstract][Full Text] [Related]
18. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
19. [Fat distribution and metabolism].
Després JP; Lemieux I; Tchernof A; Couillard C; Pascot A; Lemieux S
Diabetes Metab; 2001 Apr; 27(2 Pt 2):209-14. PubMed ID: 11452212
[TBL] [Abstract][Full Text] [Related]
20. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
Lastra G; Sowers JR
Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]